Healthcare -
Biotechnology - NASDAQ - US
$ 6.58
-0.303 %
$ 326 M
Market Cap
-1.31
P/E
RGNX - SHORT-TERM DEBT
Short-term Debt RGNX - REGENXBIO Inc.
7.07 M
LAST VALUE
42.03%
2 YEAR CAGR
0.00%
5 YEAR CAGR
26.85%
10 YEAR CAGR